Table 3 Radiation toxicity CTC ≥ 2 in patients with stage III NSCLC treated with concurrent gemcitabine and 3D radiotherapy
Toxicity | Total | Age < 70 | Age ≥ 70 | |||
|---|---|---|---|---|---|---|
N = 318 | % | N = 225 | % | N = 93 | % | |
Esophagitis | ||||||
CTC 2 | 43 | 13.6 | 32 | 14.3 | 11 | 11.8 |
CTC 3 | 29 | 9.1 | 20 | 8.9 | 9 | 9.7 |
CTC 4 | 1 | 0.3 | 1 | 0.4 | 0 | |
CTC 5 | 2 | 0.6 | 2 | 0.9 | 0 | |
Radiation pneumonitis | ||||||
CTC 2 | 52 | 17.7 | 38 | 17.0 | 14 | 15.1 |
CTC 3 | 6 | 2.0 | 2 | 0.9 | 4 | 4.3 |
CTC 4 | 1 | 0.3 | 1 | 0.4 | 0 | |
CTC 5 | 3 | 0.9 | 0 | 3 | 3.2 |